Biovail

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) stock has tumbled more than 30 percent and hit a new 52-week low of $13.77 before recovering above the $15 per share level. Investors and traders dumped Valeant's stock after the company's third quarter earnings report fell short of Wall...